News stories about Agilent Technologies (NYSE:A) have been trending positive this week, InfoTrie Sentiment reports. The research group rates the sentiment of media coverage by monitoring more than 6,000 blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Agilent Technologies earned a news impact score of 2.43 on their scale. InfoTrie also gave news headlines about the medical research company an news buzz score of 4 out of 10, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

These are some of the news stories that may have effected Agilent Technologies’ score:

A opened at $71.91 on Friday. Agilent Technologies has a 1-year low of $60.42 and a 1-year high of $75.11. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.74 and a current ratio of 3.29. The company has a market capitalization of $23.24 billion, a PE ratio of 25.77, a P/E/G ratio of 2.04 and a beta of 1.36.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Monday, November 19th. The medical research company reported $0.81 earnings per share for the quarter, beating analysts’ consensus estimates of $0.74 by $0.07. Agilent Technologies had a net margin of 6.43% and a return on equity of 19.84%. The company had revenue of $1.29 billion for the quarter, compared to the consensus estimate of $1.26 billion. During the same period last year, the company posted $0.67 EPS. The firm’s quarterly revenue was up 8.8% compared to the same quarter last year. On average, analysts expect that Agilent Technologies will post 3.04 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 23rd. Stockholders of record on Monday, December 31st will be paid a $0.164 dividend. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.15. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.91%. The ex-dividend date of this dividend is Friday, December 28th. Agilent Technologies’s dividend payout ratio (DPR) is presently 21.51%.

Agilent Technologies announced that its board has authorized a share repurchase plan on Monday, November 19th that authorizes the company to repurchase $1.75 billion in outstanding shares. This repurchase authorization authorizes the medical research company to repurchase up to 8.8% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s management believes its stock is undervalued.

A number of equities research analysts have issued reports on A shares. Morgan Stanley increased their price objective on shares of Agilent Technologies from $86.00 to $89.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 20th. ValuEngine upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Friday, November 2nd. Goldman Sachs Group restated a “buy” rating and issued a $82.00 price target (up from $77.00) on shares of Agilent Technologies in a research note on Tuesday, September 18th. Zacks Investment Research downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Tuesday, October 16th. Finally, Deutsche Bank raised their price target on shares of Agilent Technologies from $77.00 to $80.00 and gave the company a “buy” rating in a research note on Wednesday, August 15th. Two analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $78.75.

In related news, VP Rodney Gonsalves sold 1,500 shares of Agilent Technologies stock in a transaction that occurred on Wednesday, November 28th. The shares were sold at an average price of $71.06, for a total transaction of $106,590.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Michael R. Mcmullen sold 15,923 shares of Agilent Technologies stock in a transaction that occurred on Monday, December 3rd. The stock was sold at an average price of $73.20, for a total transaction of $1,165,563.60. Following the sale, the chief executive officer now owns 492,546 shares in the company, valued at $36,054,367.20. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 34,683 shares of company stock worth $2,499,491.

WARNING: This piece was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another site, it was copied illegally and republished in violation of U.S. & international copyright law. The correct version of this piece can be viewed at

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.

Read More: Compound Annual Growth Rate (CAGR)

Insider Buying and Selling by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with's FREE daily email newsletter.